IP Library Granted Patent US 10,945,970
Granted Patent B2
US 10,945,970 · App. 16/111,502 · Granted Mar 16, 2021

Curcumin-based compositions and methods of use thereof

Inventor: Franco Cavaleri (Surrey, CA)
A61K31/12A61K9/485A61K9/4858A61K9/4866A61P3/06A61K36/9066A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,945,970
App. No.
16/111,502
Granted
Mar 16, 2021
Kind
B2
Abstract

Methods and compositions for increasing LDL receptor levels in a plurality of cells are disclosed. For example, the methods include providing to the cells a curcumin composition that is at least 15% curcumin II or at least 5% curcumin III, in order to increase LDL receptor levels. In addition, compositions for increasing LDL receptor levels in a plurality of cells are disclosed, which include a curcumin composition consisting of at least 15% curcumin II or at least 5% curcumin III (or combinations of such curcuminoids), along with a pharmaceutically-acceptable solvent, filler, or carrier. Still further, methods and compositions for decreasing MSK1 levels in a plurality of cells are disclosed, which involve administering a curcumin III-enriched composition to the cells.

Claims (16)

1. A composition that comprises:

(a) 30-40% curcumin I;

(b) 9-11% curcumin II; and

(c) 45%-55% curcumin III, wherein the composition is formulated as a capsule, pill, tablet, granule, solution or a suspension in an aqueous or non-aqueous liquid, oil-in-water or water-in-oil emulsion, elixir, syrup, paste, or dry powder.

2. The composition of claim 1 , which comprises about 35% curcumin I, about 10% curcumin II, and about 50% curcumin III.

3. The composition of claim 1 , wherein the composition is formulated as the capsule, which further comprises hydroxypropyl methylcellulose, water, microcrystalline cellulose, magnesium stearate, and silicon dioxide.

4. A composition that comprises:

(a) 45-55% curcumin I;

(b) 10-20% curcumin II; and

(c) 20%-40% curcumin III, wherein the composition is formulated as a capsule, pill, tablet, granule, solution or a suspension in an aqueous or non-aqueous liquid, oil-in-water or water-in-oil emulsion, elixir, syrup, paste, or dry powder.

5. The composition of claim 4 , which comprises about 50% curcumin I, about 15% curcumin II, and about 30% curcumin III.

6. The composition of claim 4 , wherein the composition is formulated as the capsule, which further comprises hydroxypropyl methylcellulose, water, microcrystalline cellulose, magnesium stearate, and silicon dioxide.

7. A composition that comprises a curcumin extract, which is supplemented with additional (a) curcumin II, (b) curcumin III, or (c) both curcumin II and curcumin III, such that the composition comprises:

(i) at least 50% curcumin II; or

(ii) at least 50% curcumin III,

wherein the composition is formulated as a capsule, pill, tablet, granule, solution or a suspension in an aqueous or non-aqueous liquid, oil-in-water or water-in-oil emulsion, elixir, syrup, paste, or dry powder.

Continuity (3)
Continuation In Part PCTCA2018050275 · Mar 8, 2018
Provisional Application 62469554 · Mar 10, 2017
Related Publication 20180360774A1 · Dec 20, 2018